EUR 104.0
(1.86%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.91 Billion EUR | 2.83% |
2022 | 1.9 Billion EUR | 27.16% |
2021 | 1.49 Billion EUR | -8.6% |
2020 | 1.63 Billion EUR | -25.86% |
2019 | 2.21 Billion EUR | 58.67% |
2018 | 1.39 Billion EUR | 11.85% |
2017 | 1.24 Billion EUR | 22.6% |
2016 | 1.01 Billion EUR | 7.84% |
2015 | 942.5 Million EUR | 15.94% |
2014 | 812.9 Million EUR | 4.06% |
2013 | 781.2 Million EUR | -7.78% |
2012 | 847.08 Million EUR | 7.48% |
2011 | 788.13 Million EUR | 11.77% |
2010 | 705.15 Million EUR | 0.43% |
2009 | 702.1 Million EUR | 10.48% |
2008 | 635.47 Million EUR | 8.47% |
2007 | 585.85 Million EUR | 20.59% |
2006 | 485.81 Million EUR | 7.79% |
2005 | 450.71 Million EUR | 9.66% |
2004 | 411 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.11 Billion EUR | 0.0% |
2023 FY | 1.95 Billion EUR | 2.83% |
2023 Q4 | 818.9 Million EUR | 0.0% |
2023 Q2 | 1.09 Billion EUR | 0.0% |
2022 FY | 1.9 Billion EUR | 27.16% |
2022 Q2 | 755.59 Million EUR | 0.0% |
2022 Q4 | 1.15 Billion EUR | 0.0% |
2021 FY | 1.49 Billion EUR | -8.6% |
2021 Q2 | 693 Million EUR | 0.0% |
2021 Q4 | 805.69 Million EUR | 0.0% |
2020 FY | 1.63 Billion EUR | -25.86% |
2020 Q4 | 857 Million EUR | 0.0% |
2020 Q2 | 782.69 Million EUR | 0.0% |
2019 Q4 | 1.45 Billion EUR | 0.0% |
2019 Q2 | 759.9 Million EUR | 0.0% |
2019 FY | 2.21 Billion EUR | 58.67% |
2018 Q4 | 745.2 Million EUR | 0.0% |
2018 FY | 1.39 Billion EUR | 11.85% |
2018 Q2 | 648.6 Million EUR | 0.0% |
2017 Q4 | 635.3 Million EUR | 0.0% |
2017 FY | 1.24 Billion EUR | 22.6% |
2017 Q2 | 610.8 Million EUR | 0.0% |
2016 Q2 | 460.29 Million EUR | 0.0% |
2016 Q4 | 556.1 Million EUR | 0.0% |
2016 FY | 1.01 Billion EUR | 7.84% |
2015 Q4 | 468.79 Million EUR | 0.0% |
2015 Q2 | 473.7 Million EUR | 0.0% |
2015 FY | 942.5 Million EUR | 15.94% |
2014 FY | 812.9 Million EUR | 4.06% |
2014 Q4 | 445.59 Million EUR | 0.0% |
2014 Q2 | 367.29 Million EUR | 0.0% |
2013 Q2 | 383.9 Million EUR | 0.0% |
2013 Q4 | 397.3 Million EUR | 0.0% |
2013 FY | 781.2 Million EUR | -7.78% |
2012 Q3 | 318.59 Million EUR | 0.0% |
2012 FY | 847.08 Million EUR | 7.48% |
2012 Q1 | 318.59 Million EUR | 0.0% |
2012 Q2 | 318.59 Million EUR | 0.0% |
2012 Q4 | - EUR | -100.0% |
2011 Q2 | -249.2 Million EUR | 0.0% |
2011 Q1 | -249.2 Million EUR | 0.0% |
2011 FY | 788.13 Million EUR | 11.77% |
2011 Q4 | - EUR | 100.0% |
2011 Q3 | -249.2 Million EUR | 0.0% |
2010 FY | 705.15 Million EUR | 0.43% |
2010 Q4 | - EUR | -100.0% |
2010 Q3 | 294.44 Million EUR | 0.0% |
2010 Q1 | 294.44 Million EUR | 0.0% |
2010 Q2 | - EUR | -100.0% |
2009 Q1 | 268.64 Million EUR | 9.1% |
2009 Q2 | 268.64 Million EUR | 0.0% |
2009 Q3 | 268.64 Million EUR | 0.0% |
2009 Q4 | - EUR | -100.0% |
2009 FY | 702.1 Million EUR | 10.48% |
2008 FY | 635.47 Million EUR | 8.47% |
2008 Q4 | 246.23 Million EUR | 0.0% |
2008 Q3 | 246.23 Million EUR | 0.0% |
2008 Q2 | 246.23 Million EUR | 0.0% |
2008 Q1 | 246.23 Million EUR | 6.52% |
2007 FY | 585.85 Million EUR | 20.59% |
2007 Q2 | 231.17 Million EUR | 0.0% |
2007 Q1 | 231.17 Million EUR | 68.51% |
2007 Q3 | 231.17 Million EUR | 0.0% |
2007 Q4 | 231.17 Million EUR | 0.0% |
2006 Q4 | 137.18 Million EUR | 0.0% |
2006 Q3 | 137.18 Million EUR | 0.0% |
2006 Q2 | 137.18 Million EUR | 0.0% |
2006 Q1 | 137.18 Million EUR | 4.66% |
2006 FY | 485.81 Million EUR | 7.79% |
2005 FY | 450.71 Million EUR | 9.66% |
2005 Q1 | 131.08 Million EUR | 14.07% |
2005 Q2 | 131.08 Million EUR | 0.0% |
2005 Q3 | 131.08 Million EUR | 0.0% |
2005 Q4 | 131.08 Million EUR | 0.0% |
2004 Q4 | 114.9 Million EUR | 0.0% |
2004 FY | 411 Million EUR | 0.0% |
2004 Q3 | 114.9 Million EUR | 0.0% |
2004 Q2 | 114.9 Million EUR | 0.0% |
2004 Q1 | 114.9 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
AB Science S.A. | 14.01 Million EUR | -13592.922% |
Boiron SA | 317.27 Million EUR | -504.905% |
Malin Corporation plc | 4.5 Million EUR | -42548.889% |
Vetoquinol SA | 217.11 Million EUR | -783.951% |